ROCHESTER, Mich. , July 24, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call on Wednesday, August 7, 2019 at 4:30 p.m. Eastern time to discuss results for the second quarter ended

More Than 55,000 Prescribers on the NextGen® Enterprise Network Will Have Immediate Access to OptimizeRx’s Point-of-Care Platform That Links the Pharma-Physician-Patient-Payor Continuum ROCHESTER, Mich. , July 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

ROCHESTER, Mich. , June 25, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.  (Nasdaq: OPRX) , a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap ® and 3000 ® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution,

ROCHESTER, Mich. , June 12, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.  (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has been invited to participate in the ROTH London Conference being held on June 17-19, 2019 at the Dorchester Hotel in London, U.K.

Todd Samuelson, Eze Abosi and Adam Sokol Bring more than 40 Years' Experience in Enterprise Solution Sales and Relationship Management in Healthcare, Combined with Commercialization of HCP and Patient-Centric Innovative Solutions ROCHESTER, Mich. , June 10, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

ROCHESTER, Mich. , June 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering of 1,538,500 shares of its common stock,

ROCHESTER, Mich. , June 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering of shares of its common stock.  In connection with the offering,

ROCHESTER, Mich. , May 31, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in two investor conferences being held in June. Event: William Blair & Company 39 th Annual Growth

ROCHESTER, Mich. , May 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019 . Quarterly comparisons are to the same year-ago quarter.

Combined offering integrates EHR network and proactive patient services to improve access and adherence LAS VEGAS , April 30, 2019 /PRNewswire/ --  EVERSANA ™, the leading independent provider of global services to the life science industry, and   OptimizeRx Corp.